7 results
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... million new M. tuberculosis ... (LTBI) Pathophysiology ... kidney disease • DM ... #Management #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... million new M. tuberculosis ... (LTBI) Pathophysiology ... kidney disease • DM ... #Management #Treatment
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
Multi-Drug Resistant Tuberculosis ... MultiDrugResistant #Tuberculosis ... #MDRTB #management ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Normal and Renal Dosing ... Inhibitors #Renal #Dosing ... #Pharmacology # ... Management #Diabetes ... #DM2 #Endocrinology
Acromegaly - Diagnosis and Management Summary - GrepMed Handbook 

Clinical Presentation: 
 • Classic Acromegaly: frontal
Diagnosis and Management ... Acromegaly: frontal bossing ... malignancy Pathophysiology ... #Endocrinology ... #Treatment #Pathophysiology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
Mycobacterium Tuberculosis ... Guidelines for dosing ... Mycobacterium #Tuberculosis ... #Treatment #management ... infections #HIVAIDS #pharmacology
Management of Anthracyclines and HER2 Antagonist Cardiotoxicity
Anthracyclines cause cardiomyopathy:
 ✖ Reduction in left ventricular ejection fraction
Management of Anthracyclines ... doxorubicin 150 mg/m2 ... , 350 mg/m2, and ... every 3 months during ... cardiology #oncology #pharmacology